Add to ORKGIntroduction: The aim of this study was to investigate the probable differences in P53 expression between papillary urothelial neoplasm of low malignant potential (PUNLMP) and varying grades of transitional cell carcinoma (TCC) of the bladder. Materials and Methods: Ten biopsy specimens of the patients with PUNLMP
The choice of treatment for bladder tumors is based on pathological criteria, i.e. staging and gradi...
The choice of treatment for bladder tumors is based on pathological criteria, i.e. staging and gradi...
Overexpression of p53, as determined by immunohistochemical staining with the murine monoclonal anti...
Purpose: The aim of this study was to investigate the usability of MUC1 and p53 for differential dia...
Objective: The purpose of this research was to find out how prevalent p53 overexpression is in bladd...
Background: Urothelial carcinomas (UC) is of the most common cancers urinary bladder. Aim: The aim o...
Objective: The purpose of this research was to find out how prevalent p53 overexpression is in bladd...
Immunohistochemical evaluation of p53 protein in bladder Transitional Cell Carcinom
Objective To determine whether p53 expression is a marker of tumour progression in superficially inv...
Introduction: Urinary bladder cancer is one of the common genitourinary malignancy presenting to the...
Objective: The aim of this work is to determine the value of P53 as a biochemical marker in patients...
ObjectivesTo study the incidence of p53 oncoprotein overexpression and its relationship to tumour gr...
To establish the importance of immunohistochemical staining of P53 in grading of Urothelial Carcinom...
The choice of treatment for bladder tumors is based on pathological criteria, i.e. staging and gradi...
Contains fulltext : 21736___.PDF (publisher's version ) (Open Access
The choice of treatment for bladder tumors is based on pathological criteria, i.e. staging and gradi...
The choice of treatment for bladder tumors is based on pathological criteria, i.e. staging and gradi...
Overexpression of p53, as determined by immunohistochemical staining with the murine monoclonal anti...
Purpose: The aim of this study was to investigate the usability of MUC1 and p53 for differential dia...
Objective: The purpose of this research was to find out how prevalent p53 overexpression is in bladd...
Background: Urothelial carcinomas (UC) is of the most common cancers urinary bladder. Aim: The aim o...
Objective: The purpose of this research was to find out how prevalent p53 overexpression is in bladd...
Immunohistochemical evaluation of p53 protein in bladder Transitional Cell Carcinom
Objective To determine whether p53 expression is a marker of tumour progression in superficially inv...
Introduction: Urinary bladder cancer is one of the common genitourinary malignancy presenting to the...
Objective: The aim of this work is to determine the value of P53 as a biochemical marker in patients...
ObjectivesTo study the incidence of p53 oncoprotein overexpression and its relationship to tumour gr...
To establish the importance of immunohistochemical staining of P53 in grading of Urothelial Carcinom...
The choice of treatment for bladder tumors is based on pathological criteria, i.e. staging and gradi...
Contains fulltext : 21736___.PDF (publisher's version ) (Open Access
The choice of treatment for bladder tumors is based on pathological criteria, i.e. staging and gradi...
The choice of treatment for bladder tumors is based on pathological criteria, i.e. staging and gradi...
Overexpression of p53, as determined by immunohistochemical staining with the murine monoclonal anti...